tiprankstipranks
Clinuvel Pharmaceuticals Limited Sponsored ADR (CUVL)
NASDAQ:CUVL
US Market
CUVL
Clinuvel Pharmaceuticals Limited Sponsored ADR
RESEARCH TOOLSreports

Clinuvel Pharmaceuticals Limited Sponsored ADR (CUVL) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CUVL Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Clinuvel
Pharmaceuticals Limited Sponsored ADR
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CUVL Stock 12 Month Forecast

There Are No Analyst Ratings for CUVL In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CUVL Financial Forecast

CUVL Earnings Forecast

Next quarter’s earnings estimate for CUVL is $0.32 with a range of $0.27 to $0.35. The previous quarter’s EPS was $0.15. CUVL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.87% of the time in the same period. In the last calendar year CUVL has Performed in-line its overall industry.
Next quarter’s earnings estimate for CUVL is $0.32 with a range of $0.27 to $0.35. The previous quarter’s EPS was $0.15. CUVL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.87% of the time in the same period. In the last calendar year CUVL has Performed in-line its overall industry.

CUVL Sales Forecast

Next quarter’s sales forecast for CUVL is $42.23M with a range of $38.95M to $43.98M. The previous quarter’s sales results were $24.20M. CUVL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.90% of the time in the same period. In the last calendar year CUVL has Performed in-line its overall industry.
Next quarter’s sales forecast for CUVL is $42.23M with a range of $38.95M to $43.98M. The previous quarter’s sales results were $24.20M. CUVL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.90% of the time in the same period. In the last calendar year CUVL has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

CUVL Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

CUVL Stock Forecast FAQ

What is CUVL’s average 12-month price target, according to analysts?
Currently, no data Available
What is CUVL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CUVL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CUVL a Buy, Sell or Hold?
      Currently, no data Available
      What is Clinuvel Pharmaceuticals Limited Sponsored ADR’s price target?
      Currently, no data Available
      What do analysts say about Clinuvel Pharmaceuticals Limited Sponsored ADR?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CUVL?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.